Adjunctive Study of AL-37807 Ophthalmic Suspension

• Status: Completed
• Trial end date: 2008-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to compare the safety and intraocular pressure-lowering efficacy of AL-37807 ophthalmic suspension vs. Timolol gel forming solution vs. AL-37807 vehicle, all dosed concomitantly with Xalatan, in patients with open-angle glaucoma or ocular hypertension.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Latanoprost; Ophthalmic Solutions; Pharmaceutical Solutions; Timolol

Criteria

Inclusion Criteria:

• Open-angle glaucoma

• Ocular hypertension

• Must have been on Xalatan for at least 3 months

• VA not worse than 0.60

• Other protocol-defined inclusion criteria may apply

Exclusion Criteria:

• Age related

• Other protocol-defined exclusion criteria may apply